Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 2/2007

01-04-2007 | Original Paper

Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection

Authors: Atsushi Okada, Shintaro Nomura, Yuji Higashibata, Masahito Hirose, Bing Gao, Mugi Yoshimura, Yasunori Itoh, Takahiro Yasui, Keiichi Tozawa, Kenjiro Kohri

Published in: Urolithiasis | Issue 2/2007

Login to get access

Abstract

The establishment of an experimental animal model would be useful to study the mechanism of kidney stone formation. A calcium kidney stone model in rats induced by ethylene glycol has been used for research; however, to investigate the genetic basis affecting kidney stone formation, which will contribute to preventive medicine, the establishment of a kidney stone model in mice is essential. This study indicates the optimum conditions for inducing calcium oxalate stones in normal mouse kidney. Various doses of oxalate precursors, ethylene glycol, glycolate and glyoxylate, were administered either by free drinking or intraabdominal injection for 2 months as a preliminary study. Stone formation was detected with light microscopy, polarized light optical microscopy and electron microscopy. Stone components were detected with X-ray diffraction analysis. The expression of osteopontin (OPN), a major stone-related protein, was detected with immunohistochemical staining, in situ hybridization and quantitative reverse transcriptase polymerase chain reaction. Kidney stones were not detected in ethylene glycol- or glycolate-treated groups even at the highest dose of LD50. Whereas, numerous kidney stones were detected in glyoxylate-treated mice (more than 60 mg/kg) at 3, 6 and 9 days after glyoxylate were administered intraabdominally. However, the number of kidney stones decreased gradually at day 12, and was hardly detected at day 15. The stone component was further analyzed as calcium oxalate monohydrate. A dramatic increase in the expression of OPN was observed by the administration of glyoxylate. We established a mouse kidney stone experimental system in this study. The difficulty of inducing kidney stones suggested that mice have greater intrinsic ability to prevent stone formation with hyperoxaluric stress than rats. The differing response to hyperoxaluric stress between mice and rats possibly contributes to the molecular mechanism of kidney stone formation and will aid preventive medicine in the future.
Literature
1.
Khan SR (1995) Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones. Scanning Microsc 9:89PubMed
2.
Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173–1181PubMedCrossRef
3.
Harris KS, Richardson KE (1980) Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 18:106–109PubMed
4.
Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, Yamate T, Umekawa T, Suzuki Y, Sinohara H (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180–15184PubMed
5.
Harris KS, Richardson KE (1980) Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 18:106–109PubMed
6.
Katsuma S, Shiojima S, Hirasawa A, Takagaki K, Kaminishi Y, Koba M, Hagidai Y, Murai M, Ohgi T, Yano J, Tsujimoto G (2002) Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 23:544–552CrossRef
7.
Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2005) Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 12:290–298PubMedCrossRef
8.
Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T (1995) Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55:6–10PubMedCrossRef
9.
Yasui T, Sato M, Fujita K, Tozawa K, Nomura S, Kohri K (2001) Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 29:50–56PubMedCrossRef
10.
Yasui T, Sato M, Fujita K, Ito Y, Nomura S, Kohri K (2001) Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model. Nephron 87:170–176PubMedCrossRef
11.
Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167:2192–2197PubMedCrossRef
12.
Eguchi Y, Inoue M, Iida S, Matsuoka K, Noda S (2002) Heparan sulfate (HS)/heparan sulfate proteoglycan (HSPG) and bikunin are up-regulated during calcium oxalate nephrolithiasis in rat kidney. Kurume Med J 49:99–107PubMed
13.
Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687–1692PubMedCrossRef
14.
Sakly R, Chaouch A, el Hani A, Najjar MF (2003) Effects of intraperitoneally administered vitamin E and selenium on calcium oxalate renal stone formation: experimental study in rat. Ann Urol (Paris) 37:47–50
15.
Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117–126PubMedCrossRef
16.
Ogawa Y, Tanaka T, Yamaguchi K, Morozumi M, Kitagawa R (1987) Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats. Hinyokika Kiyo 33:1772–1777PubMed
17.
Umekawa T, Kohri K, Kurita T, Hirota S, Nomura S, Kitamura Y (1995) Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem Mol Biol Int 35:223PubMed
18.
Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184:859PubMedCrossRef
19.
Yagisawa T, Chandhoke PS, Fan J, Lucia S (1998) Renal osteopontin expression in experimental urolithiasis. J Endourol 12:171PubMedCrossRef
20.
Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139PubMedCrossRef
21.
Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR (2004) Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66:1159–1166PubMedCrossRef
22.
Pizzolato P (1964) Histochemical recognition of calcium oxalate. J Histochem Cytochem 12:333PubMed
23.
Gibson UEM, Heid CA, Willams PMA (1996) Novel method for real-time quantitative RT-PCR. Genome Res 6:995PubMed
24.
Nomura S, Willis AJ, Edward DR, Heath JK, Hogan BLH (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106:441PubMedCrossRef
25.
Shimada T, Shindo M, Miyazawa M (2000) Species differences in metabolism of (+)- and (−)-limonenes and their metabolites, carneols and carvones, by cytochrome P450 enzymes in liver microsomes of mice, rats, guinea pigs, rabbits, dogs, monkeys, and humans. Drug Metab Phrmacokin 17:507–515CrossRef
26.
Yoshihara H, Yamaguchi S, Yachiku S (1999) Effect of sex hormones on oxalate-synthesizing enzymes in male and female rat livers. J Urol 161:668–673PubMedCrossRef
27.
Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA (2001) Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis 38:339–348PubMed
28.
de Water R, Noordermeer C, Houtsmuller AB, Nigg AL, Stijnen T, Schroder FH, Kok DJ (2000) Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis 36:615–625PubMed
29.
de Water R, Noordermeer C, van der Kwast TH, Nizze H, Boeve ER, Kok DJ, Schroder FH (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761–771PubMed
30.
de Bruijn WC, de Water R, van Run PR, Boeve ER, Kok DJ, Cao LC, Romijn HC, Verkoelen CF, Schroder FH (1997) Ultrastructural osteopontin localization in papillary stones induced in rats. Eur Urol 32:360–367PubMed
31.
Poldelski V, Johnson A, Wright S, Rosa VD, Zager RA (2001) Ethylene glycol-mediated tubular injury: identification of critical metabolites and injury pathways. Am J Kidney Dis 38:339–348PubMed
32.
Tiselius HG, Ferraz RR, Heilberg IP (2003) An approximate estimate of the ion-activity product of calcium oxalate in rat urine. Urol Res 31:410–413PubMedCrossRef
Metadata
Title
Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection
Authors
Atsushi Okada
Shintaro Nomura
Yuji Higashibata
Masahito Hirose
Bing Gao
Mugi Yoshimura
Yasunori Itoh
Takahiro Yasui
Keiichi Tozawa
Kenjiro Kohri
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 2/2007
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-007-0082-8

Other articles of this Issue 2/2007

Urolithiasis 2/2007 Go to the issue

Original Paper

Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function

Original Paper

Percutaneous nephrolithotomy in patients with normal versus impaired renal function

Original Paper

Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors

Original Paper

Models for protein binding to calcium oxalate surfaces

Original Paper

Ureteral access sheath insertion forces: implications for design and training

Original Paper

African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III